Leadership Overview
Shilpa Medicare has 4 executives leading key functions including finance, operations, biopharma CDMO licensing, and North American CDMO business.
Driven by a commitment to innovation, Shilpa Medicare focuses on manufacturing and selling active pharmaceutical ingredients, intermediates, and formulations, impacting global healthcare through its diverse product portfolio and contract manufacturing services.
Driven by a commitment to innovation, Shilpa Medicare focuses on manufacturing and selling active pharmaceutical ingredients, intermediates, and formulations, impacting global healthcare through its diverse product portfolio and contract manufacturing services.
Leadership Roles at Shilpa Medicare
Pankaj Jhawar - Chief Financial Officer
Pankaj Jhawar, the Chief Financial Officer at Shilpa Medicare, directs all financial operations and strategic fiscal planning. Overseeing budgeting, forecasting, and financial reporting, the Chief Financial Officer ensures robust fiscal health across the organization. This leadership role involves managing capital allocation, optimizing financial performance, and securing funding for expansion initiatives. By analyzing market trends and economic conditions, Pankaj Jhawar drives financial strategies that support the company's growth in active pharmaceutical ingredients (APIs), intermediates, and formulations. Ultimately, Jhawar safeguards the company's financial stability and enhances shareholder value through meticulous financial oversight.
Jayant Karajgi - Chief Operating Officer
Jayant Karajgi, the Chief Operating Officer at Shilpa Medicare, oversees the end-to-end manufacturing and operational efficiency of the company's diverse product lines. Managing the production of active pharmaceutical ingredients (APIs), intermediates, and finished formulations, the Chief Operating Officer ensures seamless execution of manufacturing processes. This critical role involves optimizing supply chain logistics, enhancing production quality, and driving operational improvements across all facilities, including those involved in new drug delivery systems and specialty chemicals. By streamlining workflows and implementing best practices, Jayant Karajgi directly contributes to the company's capacity for contract manufacturing of various dosage forms, from tablets to sterile injectables. Karajgi's leadership ensures consistent product delivery and operational excellence.
Harshawardhan Bal - President, Biopharma Cdmo Licensing & Partnering (Ai Ml Discovery Development & Manufacturing)
Harshawardhan Bal, the President, Biopharma Cdmo Licensing & Partnering (Ai Ml Discovery Development & Manufacturing) at Shilpa Medicare, spearheads the strategic expansion of biopharmaceutical contract development and manufacturing organization (CDMO) services. This executive directs licensing agreements and partnership initiatives, focusing on integrating artificial intelligence and machine learning into discovery, development, and manufacturing processes. Overseeing the identification and cultivation of new business opportunities, Harshawardhan Bal ensures Shilpa Medicare remains at the forefront of biopharmaceutical innovation. The scope of this role encompasses forging global alliances and securing intellectual property rights for novel therapeutic solutions. Bal's strategic vision drives the company's engagement in advanced biopharmaceutical manufacturing and development.
Harsh Bal - President, Cdmo Business (North America )
Harsh Bal, the President, Cdmo Business (North America ) at Shilpa Medicare, leads the strategic growth and operational execution of the company's contract development and manufacturing organization (CDMO) business within the North American market. This executive directs all aspects of CDMO operations in the region, including client acquisition, project management, and service delivery for various dosage forms. Overseeing the expansion of Shilpa Medicare's presence in North America, Harsh Bal ensures alignment with market demands for oncology and non-oncology APIs, intermediates, and specialized injectables. By fostering strong client relationships and driving operational excellence, Bal enhances Shilpa Medicare's reputation as a reliable CDMO partner. This leadership role is pivotal in capturing market share and driving revenue growth across the United States and Canada.
Explore Leadership Teams in Manufacturing
Teva Pharmaceutical Industries Ltd. is a global biopharmaceutical leader focused on improving health outcomes for patients worldwide. Enabled by a world-class generics business, Teva develops, manufactures, and delivers a broad portfolio of medicines, including complex generics, biosimilars, innovative therapies, and pharmacy brands. The company is dedicated to addressing unmet patient needs by advancing scientific research, expanding access to quality medicines, and streamlining the delivery of treatments -from established generics to cutting-edge therapeutic solutions.
Company Leadership CS
HL
AJ
CO
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership BG
NP
NC
Cresco Labs is a multi-state, vertically integrated cannabis company that controls its cultivation, manufacturing, extraction, and packaging practices. Its facilities are powered by agronomists, manufacturing experts, and state-of-the-art agricultural equipment, all of which drive their commitment to quality, purity, and consistency. Cresco Labs packages, ships and distributes its products nationwide, including locations owned and operated by their team. Cresco Labs is headquartered in Chicago, Illinois.
Company Leadership DD
CR
GB
Crown Laboratories, founded in 2000 and based in Johnson City, TN, provides pharmaceutical and ethical OTC products to the medical marketplace and contract manufacturing to the pharmaceutical industry.
Company Leadership JT
KO
JS
Frequently Asked Questions Regarding Shilpa Medicare Top Executives and Leadership Team
